Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
37,778,373
-
Total 13F shares
-
27,576,793
-
Share change
-
+5,317,837
-
Total reported value
-
$1,242,993,864
-
Put/Call ratio
-
34%
-
Price per share
-
$45.07
-
Number of holders
-
119
-
Value change
-
+$212,594,407
-
Number of buys
-
81
-
Number of sells
-
64
Institutional Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q2 2024
As of 30 Jun 2024,
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,576,793 shares.
The largest 10 holders included
Paradigm Biocapital Advisors LP, Atlas Venture Life Science Advisors, LLC, Bain Capital Life Sciences Investors, LLC, ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Frazier Life Sciences Management, L.P., BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.